A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck announces positive results from phase 3 KEYNOTE-966 trial of Keytruda in combo with chemotherapy to treat advanced or unresectable biliary tract cancer
Published: January 27, 2023 by PharmaBiz (India)
Janssen and global partners to discontinue Phase 3 Mosaico HIV vaccine clinical trial after data showed the regimen was not effective in preventing HIV infection compared to placebo; in 2021, 1.5 million people acquired HIV
Published: January 18, 2023 by Johnson & Johnson Services Inc.
Pfizer reports positive top-line results from Phase 3 study of fidanacogene elaparvovec hemophilia B gene therapy candidate; treatment is a novel vector with a bio-engineered adeno-associated virus capsid and a high-activity human coagulation FIX gene
Published: December 29, 2022 by Business Wire
Pfizer lists new Phase 3 clinical trial to study ARV-471PF-07850327 as treatment for advanced metastatic breast cancer
Published: December 20, 2022 by Contify Life Science News
AstraZeneca listed a new Phase 3 clinical trial to study for immunocompromised patients for pre exposure prophylaxis of COVID-19 with AZD5156
Published: December 15, 2022 by Contify Life Science News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count